Category
Cancer
Sub Category
Lung
Study Name
S0819, “A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC).
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Patient must have non small cell lung cancer, stage IV. Must be new or recurrent after surgery and or radiation.
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance